EdentulismNCT01340170
A Study Evaluating OsseoSpeed TX Using Different Drilling Protocols With Immediate Loading
A study testing OsseoSpeed TX in people with Edentulism, run by Dentsply Sirona Implants and Consumables at 9 sites in Italy.
Trial summary
This study is initiated to support the OsseoSpeedTM TX implant with clinical data showing that a soft bone drilling protocol and immediate loading does not have any important negative effect on marginal bone level maintenance. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Edentulism
- What is being tested?
- OsseoSpeed TX
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 168 participants
- Where
- 9 sitesItaly
- Study dates
- Apr 2011to Dec 2014
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Provision of informed consent
- Female/male aged 18 years and over
- History of edentulism in the study area of at least 3 months
- At least 4 months healing after last grafting procedure in the study area
- In need for implant treatment replacing one to four missing single tooth in positions 14-17, 24-27, 34-37 and 44-47
- The study implant position must be surrounded by natural tooth roots, unless the implant will constitute the most distal dentition.
Show all 10Show fewer
- Deemed by the investigator to be suitable for one stage surgery
- Deemed by the investigator to be suitable for immediate loading
- Deemed by the investigator as likely to present an initially stable implant situation.
- Deemed by the investigator to have a "functional" opposing dentition at the time of loading the implants.
Who cannot join
- Unlikely to be able to comply with study procedures, as judged by the investigator
- Uncontrolled pathological processes in the oral cavity
- Known or suspected current malignancy
- History of radiation therapy in the head and neck region
- History of chemotherapy within 5 years prior to surgery
- Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
Show all 13Show fewer
- Uncontrolled diabetes mellitus
- Corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration
- Present alcohol and/or drug abuse
- Current need for bone grafting and/or augmentation in the planned implant area
- Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
- Previous enrolment in the present study.
- Simultaneous participation in another clinical study, or participation in a clinical study during the last 6 months.
Trial locations and contacts
9 sites in 1 country.
9 sites in 1 country
Italy9 sites
Studio Associato Maffei
Bari
Studio Dentistico Paolo Torrisi
Catania, 95125
Societa diMedicina Odontostomatologica Srl
Como, 22100
Dept. of Oral Sciences "S. Palazzi", University of Pavia
Pavia, 27100
Studio Dentistico
Perugia, 06038
La Scala & Partners Studio Associato
Pistoia, 51100
Studio Odontoiatrico
Roma, 00192
Studio Dentistico
Torino, 10143
Studio Polispecialistico di Odontoiatria
Udine, 33100
About this study
Official title: An Open, Non-randomized, Prospective Multi-centre Study Evaluating a Soft Bone Drilling Protocol for Single Tooth Restoration in the Posterior Area With Immediate Loading
This study is initiated to support the OsseoSpeedTM TX implant with clinical data showing that a soft bone drilling protocol and immediate loading does not have any important negative effect on marginal bone level maintenance.
Read the detailed description
This study is designed to evaluate a soft bone drilling protocol compared to a standard bone drilling protocol when using OsseoSpeedTM TX with regards to marginal bone level changes and implant survival rate one year after loading. The aim is also to investigate potential differences in initial stability and in general user friendliness between the two drilling protocols.
- Conditions
- Edentulism
- Being tested
- OsseoSpeed TX
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
OsseoSpeed TXDevice
OsseoSpeed TX dental implants, 6-17 mm
| Study group | Role | What they receive |
|---|---|---|
| Soft bone drilling protocol | Experimental | A soft bone drilling protocol will be used in bone quality 3 and 4 Receives: Device: OsseoSpeed TX |
| Standard drilling protocol | Active comparator | A standard drilling protocol will be used in bone quality 1 and 2 Receives: Device: OsseoSpeed TX |
What is being measured
The primary outcome is the main question the study is designed to answer.
Marginal Bone Level Change
Marginal Bone Level alterations will be determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
Measured: Implant insertion and 12 months post implant insertion
Secondary outcomes (7)
Marginal Bone Level Change
Marginal Bone Level alterations will be determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
Measured: Implant insertion and 3 months post implant insertion
Implant Survival Rate
Implant survival rate will be evaluated by both clinically and radiographically counting the number of remaining implants from implant placement to one year after loading.
Measured: 12 months after baseline, i.e., implant insertion
Implant Stability Assessed Clinically/Manually
Evaluated clinically/manually and recorded as stable yes/no.
Measured: At implant insertion
Implant Stability Using Resonance Frequency Analysis (RFA)
The Osstell® instrument "Osstell® ISQ" will be used to measure RFA. RFA measures the frequency with which a device vibrates. By comparing resonance frequencies the stability of a dental implant can be determined as the resonance frequency changes with different stability. The Osstell® ISQ instrument translates the RFA value into an Implant Stability Quotient (ISQ) scale value. ISQ is a scale from 1 to 100. The ISQ scale has a non-linear correlation to micro mobility, with a higher value corresponding to increased stability.
Measured: At implant insertion.
Perception During Implant Insertion - "The Implant Was Guided Into the Prepared Osteotomy"
After implant insertion, a questionnaire will be completed for each study implant by the surgeon. The questionnaire contains following statements "The implant was guided into the prepared osteotomy", "The implant followed the prepared osteotomy" and "The implant has a good primary stability". The surgeon records his/her response to each statement with a number from 1 to 10 , where 1= totally disagree with the statement, and 10= totally agree with the statement.
Measured: After implant insertion
Perception During Implant Insertion - "The Implant Followed the Prepared Osteotomy"
After implant insertion, a questionnaire will be completed for each study implant by the surgeon. The questionnaire contains following statements "The implant was guided into the prepared osteotomy", "The implant followed the prepared osteotomy" and "The implant has a good primary stability". The surgeon records his/her response to each statement with a number from 1 to 10 , where 1= totally disagree with the statement, and 10= totally agree with the statement.
Measured: After implant insertion
Perception During Implant Insertion - "The Implant Has a Good Primary Stability"
After implant insertion, a questionnaire will be completed for each study implant by the surgeon. The questionnaire contains following statements "The implant was guided into the prepared osteotomy", "The implant followed the prepared osteotomy" and "The implant has a good primary stability". The surgeon records his/her response to each statement with a number from 1 to 10 , where 1= totally disagree with the statement, and 10= totally agree with the statement.
Measured: After implant insertion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2011 (estimated)
- Study startApr 2011
- Primary completionDec 2014
- Study completionDec 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for EdentulismStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 168 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dentsply Sirona Implants and Consumables
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Ruggero Rodriguez y Baena, Prof, Principal investigator, University of Pavia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01340170
- Sponsor's protocol ID
- YA-OTX-0002
- Status last verified
- Mar 2024
- First submitted
- 21 Apr 2011
- Last updated
- 15 Nov 2024
- Results posted
- Yes, on ClinicalTrials.gov
Study at a glance
From the registry record, last updated by the sponsor on 15 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Open, Non-randomized, Prospective Multi-centre Study Evaluating a Soft Bone Drilling Protocol for Single Tooth Restoration in the Posterior Area With Immediate Loading
- ClinicalTrials.gov ID
- NCT01340170
- Acronym / sponsor ID
- YA-OTX-0002
- Conditions
- Edentulism
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 168 participants (actual)
- Lead sponsor
- Dentsply Sirona Implants and ConsumablesIndustry (pharma, biotech, devices)
- Study start
- Apr 2011 (actual)
- Primary completion
- Dec 2014 (actual)
- Study completion
- Dec 2014 (actual)
- First posted
- 22 Apr 2011 (estimated)
- Results
- Posted 15 Nov 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is initiated to support the OsseoSpeedTM TX implant with clinical data showing that a soft bone drilling protocol and immediate loading does not have any important negative effect on marginal bone level maintenance.
Detailed description
This study is designed to evaluate a soft bone drilling protocol compared to a standard bone drilling protocol when using OsseoSpeedTM TX with regards to marginal bone level changes and implant survival rate one year after loading. The aim is also to investigate potential differences in initial stability and in general user friendliness between the two drilling protocols.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Soft bone drilling protocol | Experimental | Device: OsseoSpeed TXA soft bone drilling protocol will be used in bone quality 3 and 4 |
| Standard drilling protocol | Active comparator | Device: OsseoSpeed TXA standard drilling protocol will be used in bone quality 1 and 2 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Provision of informed consent
- Female/male aged 18 years and over
- History of edentulism in the study area of at least 3 months
- At least 4 months healing after last grafting procedure in the study area
- In need for implant treatment replacing one to four missing single tooth in positions 14-17, 24-27, 34-37 and 44-47
Key exclusion criteria (13 listed)
- Unlikely to be able to comply with study procedures, as judged by the investigator
- Uncontrolled pathological processes in the oral cavity
- Known or suspected current malignancy
- History of radiation therapy in the head and neck region
- History of chemotherapy within 5 years prior to surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| OsseoSpeed TXOsseoSpeed TX dental implants, 6-17 mm | Device | Soft bone drilling protocol, Standard drilling protocol |
Primary outcome
Marginal Bone Level Change
Time frame: Implant insertion and 12 months post implant insertion
Marginal Bone Level alterations will be determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.
7 secondary outcomes
Marginal Bone Level Change
Time frame: Implant insertion and 3 months post implant insertion
Implant Survival Rate
Time frame: 12 months after baseline, i.e., implant insertion
Implant Stability Assessed Clinically/Manually
Time frame: At implant insertion
Implant Stability Using Resonance Frequency Analysis (RFA)
Time frame: At implant insertion.
Perception During Implant Insertion - "The Implant Was Guided Into the Prepared Osteotomy"
Time frame: After implant insertion
Perception During Implant Insertion - "The Implant Followed the Prepared Osteotomy"
Time frame: After implant insertion
Perception During Implant Insertion - "The Implant Has a Good Primary Stability"
Time frame: After implant insertion
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Nov 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Edentulism
Recruiting
Multi-Evaluation of Dental Abutments With Different Surfaces
Edentulism, Dental Implant
Not yet recruiting
Comparative Evaluation of Artificial Intelligence-Assisted Versus Conventional Guided Implant Planning in Free End Saddle Cases
Partial Edentulism Class 1 or Class 2
Not yet recruitingObservational study
Biological Aging Following Full-Arch Implant-Supported Fixed Rehabilitation in Edentulous Patients
Edentulism, Biological Aging
Not yet recruiting
Immediate vs Conventional Loading With Different Crown Materials on Immediately Placed Single Implants
Partial Edentulism, Dental Implant
Recruiting
Accuracy of Complete-Arch Implant Scans Using Non Calibrated Splinting Scanbodies
Edentulism Complete
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ruggero Rodriguez y Baena, Prof principal investigator
University of Pavia
9 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing OsseoSpeed TX in people with Edentulism, run by Dentsply Sirona Implants and Consumables at 9 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 9 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 15 Nov 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Marginal Bone Level Change (time frame: Implant insertion and 12 months post implant insertion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2024.